2nd Quarter - Report

HEALTH AND MEDICINE COUNSEL for PULMONARY HYPERTENSION ASSOCIATION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY24 Appropriations Research & Public Health Programs FY24 Defense Appropriations FY24 HHS/DoD Approps

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
DALE P DIRKS Legislative Consultant
PHILIP GOGLAS Legislative Consultant

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Access to Disability Benefits w/Pulmonary Hypertension COPD Oxygen Access Patient-focused drug development @ FDA Healthcare Reform Patient Protections H.R.830 - HELP Copays Act S.652 - Safe Step Act

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
DALE P DIRKS Legislative Consultant
PHILIP GOGLAS Legislative Consultant

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Social Security Administration (SSA)

Bills named: H.R. 830 (118th), S. 652 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.